GREAT POINT PARTNERS LLC

Position in SCYX — Scynexis Inc

CIK 1281446 Greenwich, CT

Position in SCYX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,927,336

New position

Shares Held

7,554,347

first reported quarter

Ownership

9.51%

of shares outstanding

% of Portfolio

1.70%

of 13F equity value

Holder Rank

#2

of 44 holders

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GREAT POINT PARTNERS LLC holds $33,020,336 across 3 Drug Manufacturers - Specialty & Generic names. SCYX ranks #2 (21.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMLX	Amylyx Pharmaceuticals, Inc.	1,750,000	$24,325,000
2	SCYX	Scynexis Inc This page	7,554,347	$6,927,336
3	ALKS	Alkermes plc.	50,000	$1,768,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,927,336	7,554,347	—	Shares	Defined	2026-05-15
No filing history on record for this holder in this stock.